🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thatcher Heumann

Bloomberg (United States)

ORCID: 0000-0003-2606-3379

Also affiliated with Johns Hopkins University, Vanderbilt University, Sidney Kimmel Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma”.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9
N/A
1.4DataRank · unranked
87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

Cancer Cell(2022)10.1016/j.ccell.2022.10.001
N/A
0.778DataRank · unranked
178 citations

Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. Thomas +26 more

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.558
N/A
0.345DataRank · unranked
9 citations

Carol Judkins, Su Jin Lim, Hao Wang, Rose Parkinson, Jessica Gai +15 more

ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps639
N/A
0.230DataRank · unranked
3 citations

Mark Yarchoan, Judy Murray, Hao Wang, John Joseph Wright, Elad Sharon +3 more

Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100600
N/A
0.165DataRank · unranked
2 citations

Janelle M. Montagne, Thomas R. Nirschl, Emily F. Davis-Marcisak, Jeanette Johnson, Amanda L. Huff +10 more

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps814
N/A
0DataRank · unranked
16 citations

Thatcher Heumann, Maureen Berg, Anna Ferguson, Su Jin Lim, Hao Wang +6 more

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies

Cancers(2023)10.3390/cancers15133312
N/A
0DataRank · unranked
43 citations

Rajiv Agarwal, Laura W. Goff, Thatcher Heumann, Justin H. Lo

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma

Current Treatment Options in Oncology(2024)10.1007/s11864-023-01153-5
N/A
0DataRank · unranked
23 citations

Rajiv Agarwal, Laura W. Goff, Natalie A. Lockney, Chandrasekhar Padmanabhan, Thatcher Heumann +1 more

Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma

Advances in Oncology(2024)10.1016/j.yao.2024.02.002
N/A
0DataRank · unranked
2 citations

Rajiv Agarwal, Sara Brown, Anthony J. Borgmann, Natalie A. Lockney, Laura W. Goff +2 more

Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma

Advances in Oncology(2024)10.1016/j.yao.2024.02.001
N/A
0DataRank · unranked
0 citations

Rajiv Agarwal, Laura W. Goff, Thatcher Heumann, Daenielle Lang

Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches

Cancers(2025)10.3390/cancers17020236
N/A
0DataRank · unranked
16 citations

Thatcher Heumann, Shabnam Eghbali

End-of-life (EOL) outcomes and healthcare utilization for patients with hepatocellular carcinoma (HCC) who received immune checkpoint inhibition (ICI).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.4_suppl.560
N/A
0DataRank · unranked
0 citations

Anna-Carson Rimer Uhelski, Sarah K. Cimino, Henry J. Domenico, Sara Martin, Mohana Karlekar +5 more

Targeted therapies in advanced biliary tract cancers—a narrative review

Chinese Clinical Oncology(2023)10.21037/cco-22-93
N/A
0DataRank · unranked
19 citations

Thatcher Heumann, Laura W. Goff, Rajiv Agarwal, Michael LaPelusa

End‐Of‐Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition

Cancer Medicine(2025)10.1002/cam4.71293
N/A
0DataRank · unranked
0 citations

Anna-Carson Rimer Uhelski, Sarah K. Cimino, Henry J. Domenico, Sara Martin, Mohana Karlekar +5 more